Dr. Steven Zivko Pavletic, M.D., born in Zagreb, Croatia, in 1956 is a Medical Oncologist, Clinical Investigator, Clinical Director of the Myeloid Malignancies Program and the Head of the Graft-versus-Host and Late Effects Section of the National Cancer Institute (NCI), Center for Cancer Research, National Institutes of Health (NIH), Bethesda, Maryland. He is also an Adjunct Professor of Medicine at the Georgetown University, Lombardi Cancer Center, Division of Oncology, in Washington DC. Dr. Pavletic received his medical degree from the Zagreb University School of Medicine in Croatia. He has published more than 300 articles in peer reviewed journals. Dr. Pavletic is a member of the prestigious national Alpha Omega Alpha Honor Medical Society. Dr Pavletic is a recipient of the NCI director’s Individual Merit Award and of the National Clinical Research Foundation’s 2022 “Top 10 Clinical Research Achievement Awards”. In 2023 Dr. Pavletic is the recipient of the inaugural “Lukas Wartman” National GVHD Alliance award for his contributions to advancing clinical care of cancer patients after bone marrow transplantation. He serves in leadership roles of major US professional organizations in hematology, oncology, and bone marrow transplantation. Since 2018 he is a corresponding member of the Croatian National Academy of Arts and Sciences. In 2010 Dr. Pavletic started the Croatian professionals club in Washington DC “Hrvatska Ura”. Dr. Pavletic is a co-founder of ACAP (Association of Croatian American Professionals) established in 2014 and serves as ACAP president since 2021.
(Bethesda, Maryland, March 19, 2023)
